BlackRock Capital Allocation Trust (BCAT) Key Metrics
BCAT valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $1.38B
- Enterprise value
- $0
- P/E (TTM)
- 5.4 10-yr median 8.4
- Forward P/E
- —
- PEG ratio
- —
- Price / sales
- 5.8 10-yr median 8.3
- Price / book
- 0.9 10-yr median 0.9
- EV / EBITDA
- — 10-yr median 12.8
- Dividend yield
- 23.04% $3.00 a year
- Beta
- —
BCAT key metrics, 2020–2025
Fiscal year ended December 31, 2025 · U.S. dollarsBCAT valuation Price multiples at each fiscal year-end price.
BCAT returns How much profit the business earns on the capital it uses.
BCAT per-share figures Results divided by the shares outstanding at year-end.
BCAT financial health Debt, liquidity and how easily interest is covered.
BCAT efficiency & capital use Working capital cycle and where the cash goes.
BCAT valuation history
BCAT returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
BCAT debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
BCAT cash returned to shareholders
BCAT price vs earnings per share
BCAT key metrics
2020–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| Market capitalization | $1.50B | $1.61B | $1.72B | $1.59B | $2.14B | $2.43B |
| Enterprise value | $1.50B | $1.60B | $1.71B | $1.59B | $2.83B | $2.43B |
| P/E ratio | 6.8 | 8.3 | 8.4 | — | 17.7 | 18.9 |
| Price / sales | 6.7 | 8.1 | 8.3 | — | 17.3 | 18.9 |
| Price / book | 0.9 | 0.9 | 0.9 | 0.9 | — | 1.0 |
| Price / free cash flow | 4.6 | 4.5 | 9.5 | 1.8 | — | — |
| Price / operating cash flow | 4.6 | 4.5 | 9.5 | 1.8 | — | — |
| EV / sales | 6.7 | 8.1 | 8.3 | — | 22.9 | 18.9 |
| EV / EBITDA | 6.7 | — | 4.2 | — | 23.4 | 18.9 |
| EV / free cash flow | 4.5 | 4.5 | 9.4 | 1.8 | — | — |
| Earnings yield | 14.8% | 12.1% | 11.9% | −20.3% | 5.7% | 5.3% |
| Free cash flow yield | 21.9% | 22.0% | 10.6% | 54.5% | −27.6% | −88.2% |
| Dividend yield | 22.9% | 17.5% | 9.6% | 8.7% | 5.6% | 0.4% |
| Shareholder yield (dividends + buybacks) | 22.9% | 20.3% | 10.2% | 12.0% | 6.2% | 0.4% |
| Share price at fiscal year-end | $14.16 | $15.15 | $14.95 | $13.87 | $19.45 | $21.77 |
| Per share | ||||||
| Revenue per share | $2.12 | $1.86 | $1.80 | $0.00 | $1.12 | $1.15 |
| Earnings per share | $2.09 | $1.83 | $1.78 | −$2.81 | $1.10 | $1.15 |
| Operating cash flow per share | $3.10 | $3.34 | $1.58 | $7.56 | −$5.36 | −$19.21 |
| Free cash flow per share | $3.10 | $3.34 | $1.58 | $7.56 | −$5.36 | −$19.21 |
| Cash per share | $0.06 | $0.06 | $0.06 | $0.04 | $0.01 | $0.00 |
| Book value per share | $15.02 | $16.20 | $16.15 | $15.87 | $0.00 | $21.06 |
| Tangible book value per share | $15.02 | $16.20 | $16.15 | $15.87 | $0.00 | $21.06 |
| Dividends per share | $3.24 | $2.65 | $1.43 | $1.21 | $1.10 | $0.08 |
| Capex per share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Debt per share | — | — | — | $0.02 | $6.26 | — |
| Shares outstanding | 106.2M | 106.2M | 114.8M | 114.8M | 110.3M | 111.7M |
| Change in shares outstanding | 0.0% | −7.4% | 0.0% | +4.1% | −1.3% | — |
| Returns & profitability | ||||||
| Return on equity (ROE) | 13.4% | 10.9% | 11.1% | −35.4% | — | 5.5% |
| Return on invested capital (ROIC) | 10.6% | 8.6% | 11.2% | −20.1% | 8.0% | 5.5% |
| Return on assets (ROA) | 11.4% | 9.8% | 9.5% | −21.4% | 7.7% | 5.4% |
| Return on tangible assets | 11.3% | 10.1% | 10.0% | −14.3% | 15.8% | 5.4% |
| Free cash flow margin | 146.4% | 179.5% | 87.6% | — | −476.8% | — |
| Income quality (OCF / net income) | 1.48 | 1.83 | 0.89 | — | −4.87 | −16.71 |
| Financial health | ||||||
| Total debt | — | — | — | $1.8M | $690.6M | — |
| Cash & short-term investments | $6.8M | $6.3M | $6.9M | $4.1M | $696,393 | $189,437 |
| Net debt | −$6.8M | −$6.3M | −$6.9M | −$2.3M | $689.9M | −$189,437 |
| Debt / equity | — | — | — | 0.00 | — | — |
| Debt / assets | — | — | — | 0.00 | 0.90 | — |
| Net debt / EBITDA | −0.03 | — | −0.02 | — | 5.69 | −0.00 |
| Current ratio | 0.02 | 0.03 | 0.21 | 0.59 | 0.34 | 0.38 |
| Quick ratio | 0.02 | 0.03 | 0.04 | 0.59 | 0.34 | 0.38 |
| Interest coverage | 155.5 | 138.5 | 146.5 | -110.2 | 56.8 | — |
| Working capital | −$270.4M | −$188.2M | −$138.0M | −$108.7M | −$39.1M | −$22.2M |
| Invested capital | $1.59B | $1.71B | $1.85B | $1.82B | $689.9M | $2.35B |
| Tangible asset value | $1.60B | $1.72B | $1.85B | $1.82B | $0 | $2.36B |
| Net current asset value | −$363.7M | −$196.8M | −$157.5M | −$273.4M | −$747.4M | −$22.2M |
| Graham number | $26.57 | $25.83 | $25.46 | — | — | $23.34 |
| Graham net-net per share | −$3.42 | −$1.77 | −$1.31 | −$2.72 | −$6.82 | −$0.23 |
| Capital allocation | ||||||
| Dividends paid | $344.7M | $281.5M | $164.3M | $138.9M | $120.9M | $8.7M |
| Share buybacks (net) | — | $45.4M | $11.5M | $52.8M | $13.1M | — |
| Dividend payout ratio | 155.3% | 144.8% | 80.2% | — | 99.7% | 6.7% |
| Dividends + buybacks / free cash flow | 104.6% | 92.1% | 96.9% | 22.1% | — | — |
| Capex / revenue | 0.0% | 0.0% | 0.0% | — | 0.0% | 0.0% |
| Capex / operating cash flow | 0.0% | 0.0% | 0.0% | 0.0% | — | — |
| Capex / depreciation | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A / revenue | 0.5% | 1.1% | 0.6% | — | 1.1% | 0.2% |
| Efficiency | ||||||
| Days sales outstanding | — | 38.2 | 162.9 | — | 49.3 | 38.7 |
| Days payables outstanding | 59,143.4 | — | — | 185.8 | — | — |
| Receivables turnover | — | 9.56 | 2.24 | 0.00 | 7.41 | 9.43 |
| Payables turnover | 0.01 | 0.00 | 0.00 | 1.96 | 0.00 | 0.00 |
| Inventory turnover | — | — | 0.00 | — | — | — |
| Asset turnover | 0.12 | 0.10 | 0.10 | 0.00 | 0.08 | 0.05 |
| Average receivables | — | $20.7M | $92.3M | $87.1M | $16.7M | $13.6M |
| Average payables | $231.3M | $182.5M | $221.2M | $163.1M | $47.5M | $36.1M |
| Average inventory | — | — | $30.2M | — | — | — |
| Intangibles / total assets | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Computed from BCAT's annual financial statements (latest annual report filed December 31, 2025) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
BCAT valuation and financial ratios
At the end of fiscal 2025 (December 31, 2025), BlackRock Capital Allocation traded at 6.8 times earnings, against a 6-year median of 8.4. Based on the latest twelve months, the trailing P/E is 5.4. BlackRock Capital Allocation earned a return on equity of 13.4% and a return on invested capital of 10.6% in fiscal 2025. It returned $344.7 million to shareholders: $344.7 million in dividends and $0 in share buybacks, 105% of free cash flow. The share count fell 4.9% from 111.7M to 106.2M over 5 years.
See the BCAT income statement, the BCAT chart for price history, or the BCAT stock overview for the latest quote and news.
BCAT key metrics FAQ
What is BlackRock Capital Allocation's P/E ratio?
BlackRock Capital Allocation's trailing P/E ratio is 5.4 based on the last twelve months of earnings (as of October 18, 2026). At the end of fiscal 2025 it was 6.8, compared with a 6-year median of 8.4.
What is BlackRock Capital Allocation's EV/EBITDA?
BlackRock Capital Allocation's enterprise value was 6.7 times EBITDA at the end of fiscal 2025 (enterprise value $1.5 billion, EBITDA $222.0 million).
What is BlackRock Capital Allocation's return on equity?
BlackRock Capital Allocation's return on equity (ROE) was 13.4% in fiscal 2025: net income of $222.0 million on average shareholders' equity of $1.7 billion.
What is BlackRock Capital Allocation's ROIC?
BlackRock Capital Allocation's return on invested capital was 10.6% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
What is BlackRock Capital Allocation's dividend yield?
BlackRock Capital Allocation's forward dividend yield is 23.04%. BlackRock Capital Allocation paid $344.7 million in dividends in fiscal 2025 ($3.24 per share), a payout ratio of 155.3%.
What is BlackRock Capital Allocation's free cash flow yield?
BlackRock Capital Allocation generated $329.5 million of free cash flow in fiscal 2025, a free cash flow yield of 21.9% on its market value at year-end ($1.5 billion).
What is BlackRock Capital Allocation's current ratio?
BlackRock Capital Allocation's current ratio was 0.02 at the end of fiscal 2025: current assets were 0.02 times current liabilities.